S-Adenosylmethionine: Clinical Trials

46 trials of S-Adenosylmethionine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 4 not yet recruiting, 3 recruiting, 3 unknown. 22 Not applicable, 11 Phase 2, 8 Phase 3, 6 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 15, Active not recruiting 2, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Phase 211Completed 6, Not yet recruiting 2, Terminated 2, Recruiting 1
Phase 38Completed 8
Phase 16Completed 3, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 42Completed 2

Follow S-Adenosylmethionine: new trials by email Literature Review of S-Adenosylmethionine trials Research Report on S-Adenosylmethionine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
S-Adenosylmethionine (SAMe) - Colorectal Cancer (Diagnosis), Adenoma
Phase 1Not yet recruitingJun Gong, MD182026-11-012026-08-04
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Standard of care oxaliplatin-based chemotherapy, S-adenosylmethionine (SAMe) supplement, Surgery - Colorectal Cancer, Liver Metastases
Phase 2Not yet recruitingCedars-Sinai Medical Center302026-10-012026-09-30
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
S-adenosyl-L-methionine (SAMe), Placabo - Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Phase 2Not yet recruitingCedars-Sinai Medical Center942026-04-152026-03-31
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
Dietary supplement "Gepaktiv", UDCA (Ursodeoxycholic acid), Ademetionine - Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly
Not applicableRecruitingPhenomen Pharma902025-06-192025-07-23
Bonafide Sleep Supplement for Menopausal Women With Sleep Complaints
S-Adenosyl Methionine (SAMe), Propyl Gallate, Gamma-Aminobutyric Acid (GABA), L-Theanine, and Magnesium Glycinate - Sleep Disturbance
Not applicableCompletedBonafide Health1112025-01-032026-09-24
Bonafide Sleep Supplement for Menopausal Women With Impaired Sleep
S-Adenosyl Methionine (SAMe), Propyl Gallate, Gamma-Aminobutyric Acid (GABA), L-Theanine, and Magnesium Glycinate - Sleep Disturbances
Not applicableCompletedBonafide Health902025-01-032026-09-24
Trial of Rice-Based F-75 in Severe Malnutrition & Persistent Diarrhea in Children (SAM-RICE Study)
WHO-recommended standard therapeutic milk used for stabilization phase in SAM), HO-recommended Rice based therapeutic milk used for stabilization phase in SAM) - Severe Acute Malnutrition, Persistent Diarrhea
Not applicableCompletedChildren's Hospital and Institute of Child Health, Multan3202024-12-312025-08-24
Microbiome-Directed Food for Sustained Recovery From Acute Malnutrition
Microbiome-directed food - MAM, Ready-to-use supplementary food (RUSF), Microbiome-directed food (MDF) - SAM - Acute Malnutrition With no Complications
Not applicableNot yet recruitingInstitut de Recherche en Sciences de la Sante, Burkina Faso62002024-10-012024-03-13
From Yearly Checks to Daily Progress: Evaluating Goal Attainment Scaling (GAS) in Systematic Work Environment Management (SAM) Within the Municipal Sector
GAS for SAM - Behavior Change Interventions, Work Environment Adverse Effects
Not applicableEnrolling by invitationKarolinska Institutet452024-08-152025-10-01
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
S-Adenosyl-L-methionine (SAMe), Placebo - Primary Sclerosing Cholangitis (PSC)
Not applicableCompletedMedical University of Warsaw602023-09-012026-08-25
Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma
Anti-PD-1/PD-L1, S-Adenosyl-Methionine - Hepatocellular Carcinoma
UnknownShanghai Zhongshan Hospital202023-01-262023-02-02
S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands
S-Adenosyl-L-Methionine (Sam-E), Placebo - Osteoarthritis Hand
Phase 4CompletedDartmouth-Hitchcock Medical Center402022-08-172025-07-16
Dose-finding Study: Popliteal Sciatic Nerve Block in Patients Undergoing Diabetic Foot Surgery
Maintain the concentration of ropivacaine as same as those used in the previous participant, Decrease the ropivacaine concentration by 0.05% from the concentration used in the previous participant, Increase the ropivacaine concentration by 0.05% from the concentration used in the previous participant - Diabetic Foot, Diabetic Neuropathies
Not applicableActive not recruitingSeoul National University Hospital452021-08-242026-04-30
SAMe Trial for Patients With Alcoholic Cirrhosis
Placebo, SAMe 400 mg tablet - Alcoholic Cirrhosis
Phase 2RecruitingIndiana University1962020-10-222026-03-31
Patient-centered Mobile Technology Interventions to Improve Maternal Health in Uganda
eMobilize-Uganda application - Maternal Child Health
Not applicableCompletedMbarara University of Science and Technology1702020-08-012022-04-05
Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)
Development of a score and algorithm for TB treatment decision in hospitalised children with SAM. - Tuberculosis, Severe Acute Malnutrition
Not applicableCompletedInstitut National de la Santé Et de la Recherche Médicale, France6032019-11-042025-12-10
LAparoscopic Preventive PRErectal Mesh
Single-Anterior-Mesh, SAM, Double-Mesh, DM - Urogenital Prolapse
Not applicableRecruitingUniversity Hospital, Lille8342019-09-112026-05-22
Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
Poly-ICLC combination treatment with aPD-1 (Nivolumab or Pembrolizumab) or aPD-L1 (Atezolizumab or Durvalumab) over 6 months - Solid Cancer
Phase 1 / Phase 2TerminatedOncovir, Inc.72018-09-252021-02-01
Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma
S-Adenosyl Methionine - Primary Liver Cancer
Not applicableUnknownBeijing Insight Science & Technology Co. Ltd.2072017-07-012017-06-07
Promoting Recovery Optimization With WALKing Exercise After Stroke
FAST alone, FAST+SAM, SAM alone - Stroke
Not applicableCompletedUniversity of Delaware2502016-07-182024-10-28

Showing 20 of 46. Sign in to see all of them.

Conditions studied

Depression (4)  ·  Non-alcoholic Fatty Liver Disease (4)  ·  Carcinoma, Hepatocellular (3)  ·  Fatty Liver (3)  ·  Severe Acute Malnutrition (3)  ·  Colorectal Neoplasms (2)  ·  Disease (2)  ·  Hepatitis C (2)  ·  Liver Cirrhosis, Biliary (2)  ·  Liver Diseases (2)  ·  Malnutrition (2)  ·  Parasomnias (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Tobacco Use (2)  ·  Abdominal Pain (1)

Sponsors

Mayo Clinic (3)  ·  Abbott (2)  ·  Bonafide Health (2)  ·  Cedars-Sinai Medical Center (2)  ·  Emory University (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Baylor Research Institute (1)  ·  Beijing Insight Science & Technology Co. Ltd. (1)  ·  Children's Hospital and Institute of Child Health, Multan (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Deakin University (1)  ·  Eastern Hepatobiliary Surgery Hospital (1)  ·  Hospital Sirio-Libanes (1)  ·  Huang, Jeannie, M.D. (1)  ·  Indiana University (1)

Countries

United States (24)  ·  Poland (4)  ·  Russia (4)  ·  Australia (2)  ·  Brazil (2)  ·  China (2)  ·  France (2)  ·  India (2)  ·  Uganda (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Burkina Faso (1)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)

Top investigators

Suntje Sander-Struckmeier, PhD (2)  ·  Trisha VanDusseldorp, PhD (2)  ·  Alessandro Di Rocco, MD (1)  ·  Alexandra Gangi, MD (1)  ·  Amit Sood, M.D. (1)  ·  Ashish Mehta, MD (1)  ·  Beth L Murphy, MD, PhD (1)  ·  Charles H Halsted, MD (1)  ·  Christi A Patten, P (1)  ·  Darcy Reisman, PT, PhD (1)  ·  David Guidot, MD (1)  ·  David H Smith, MD (1)  ·  David M Guidot, MD (1)  ·  Dietland Wahner-Roedler, M.D. (1)  ·  Dr Devaraja R, MD (1)

Results publications

PMID 14639532, PMID 19422296, PMID 20561703, PMID 20697067, PMID 20854821, PMID 21079746, PMID 22044287, PMID 22065672, PMID 24067666, PMID 24500245, PMID 24699040, PMID 25055809, PMID 25470103, PMID 26011569, PMID 29649992, PMID 29777144, PMID 30240471, PMID 30245644, PMID 33317621, PMID 33345115, PMID 34767764, PMID 36862461, PMID 36944694, PMID 37230961, PMID 37609269, PMID 38134254, PMID 38298058, PMID 39007063, PMID 39606374, PMID 40291345, PMID 40312101, PMID 40323627, PMID 40361242, PMID 40637166

NIH funding

2015 (1), IK2CX000643 (1), R01AA014562 (1), R01AT000941 (1), R01AT001638 (1), R01DA025156 (1), R01HL125042 (1), R34HL117351 (1), U01AA026817 (1)